HEADER TRANSFERASE/TRANSFERASE INHIBITOR 18-AUG-20 7JTM TITLE CRYSTAL STRUCTURE OF RAR-RELATED ORPHAN RECEPTOR C (NHIS-RORGT(244- TITLE 2 487)-L6-SRC1(6T78-692) IN COMPLEX WITH A TRICYCLIC SULFONE RORGT TITLE 3 INVERSE AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEAR RECEPTOR ROR-GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NUCLEAR RECEPTOR RZR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 COMPND 5 GROUP F MEMBER 3,RAR-RELATED ORPHAN RECEPTOR C,RETINOID-RELATED COMPND 6 ORPHAN RECEPTOR-GAMMA; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: RORC, NR1F3, RORG, RZRG; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS RORGT, NUCLEAR HORMONE RECEPTOR, LIGAND-BINDING DOMAIN, INVE AGONIST, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 3 18-OCT-23 7JTM 1 REMARK REVDAT 2 07-OCT-20 7JTM 1 JRNL REVDAT 1 16-SEP-20 7JTM 0 JRNL AUTH Q.SHI,Z.XIAO,M.G.YANG,D.MARCOUX,R.J.CHERNEY,S.YIP,P.LI, JRNL AUTH 2 D.R.WU,C.A.WEIGELT,J.SACK,J.KHAN,M.RUZANOV,J.WANG,M.YARDE, JRNL AUTH 3 M.ELLEN CVIJIC,S.LI,D.J.SHUSTER,J.XIE,T.SHERRY,M.OBERMEIER, JRNL AUTH 4 A.FURA,K.STEFANSKI,G.CORNELIUS,S.CHACKO,Y.Z.SHU, JRNL AUTH 5 P.KHANDELWAL,J.HYNES JR.,J.A.TINO,L.SALTER-CID,R.DENTON, JRNL AUTH 6 Q.ZHAO,T.G.M.DHAR JRNL TITL TRICYCLIC SULFONES AS POTENT, SELECTIVE AND EFFICACIOUS ROR JRNL TITL 2 GAMMA T INVERSE AGONISTS - EXPLORING C6 AND C8 SAR USING JRNL TITL 3 LATE-STAGE FUNCTIONALIZATION. JRNL REF BIOORG.MED.CHEM.LETT. V. 30 27521 2020 JRNL REFN ESSN 1464-3405 JRNL PMID 32882417 JRNL DOI 10.1016/J.BMCL.2020.127521 REMARK 2 REMARK 2 RESOLUTION. 2.43 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (6-FEB-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 57.58 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 12209 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 622 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 32 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.43 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.46 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 394 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2117 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 379 REMARK 3 BIN R VALUE (WORKING SET) : 0.2118 REMARK 3 BIN FREE R VALUE : 0.2081 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.81 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2074 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 46 REMARK 3 SOLVENT ATOMS : 43 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.87 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.58180 REMARK 3 B22 (A**2) : -4.58180 REMARK 3 B33 (A**2) : 9.16360 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.320 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.433 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.259 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.400 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.255 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.926 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2187 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2977 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 795 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 385 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2167 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 265 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 1661 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.84 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.70 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JTM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251371. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-JUN-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : AUTOPROC, XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC, AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12259 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.430 REMARK 200 RESOLUTION RANGE LOW (A) : 57.580 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 12.40 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : 0.07400 REMARK 200 FOR THE DATA SET : 23.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.43 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.56 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.10 REMARK 200 R MERGE FOR SHELL (I) : 0.40800 REMARK 200 R SYM FOR SHELL (I) : 0.40800 REMARK 200 FOR SHELL : 6.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 6XAE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.29 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN AT 8-10MG/ML, WITH 0.2M MGCL2, REMARK 280 22% PEG3350, 0.1M BIS-TRIS PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.86000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 30.92450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 30.92450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.43000 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 30.92450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 30.92450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 118.29000 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 30.92450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 30.92450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.43000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 30.92450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 30.92450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 118.29000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 78.86000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 244 REMARK 465 GLY A 245 REMARK 465 SER A 246 REMARK 465 SER A 247 REMARK 465 HIS A 248 REMARK 465 HIS A 249 REMARK 465 HIS A 250 REMARK 465 HIS A 251 REMARK 465 HIS A 252 REMARK 465 HIS A 253 REMARK 465 SER A 254 REMARK 465 SER A 255 REMARK 465 GLY A 256 REMARK 465 LEU A 257 REMARK 465 VAL A 258 REMARK 465 PRO A 259 REMARK 465 ARG A 260 REMARK 465 GLY A 261 REMARK 465 SER A 262 REMARK 465 HIS A 263 REMARK 465 THR A 508 REMARK 465 SER A 509 REMARK 465 GLY A 510 REMARK 465 GLY A 511 REMARK 465 SER A 512 REMARK 465 GLY A 513 REMARK 465 GLY A 514 REMARK 465 LEU A 515 REMARK 465 THR A 516 REMARK 465 GLU A 517 REMARK 465 ARG A 518 REMARK 465 HIS A 519 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 265 113.88 56.99 REMARK 500 GLU A 435 73.33 -111.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VK7 A 4000 DBREF 7JTM A 265 508 UNP P51449 RORG_HUMAN 265 508 SEQADV 7JTM MET A 244 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 245 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 246 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 247 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 248 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 249 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 250 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 251 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 252 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 253 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 254 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 255 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 256 UNP P51449 EXPRESSION TAG SEQADV 7JTM LEU A 257 UNP P51449 EXPRESSION TAG SEQADV 7JTM VAL A 258 UNP P51449 EXPRESSION TAG SEQADV 7JTM PRO A 259 UNP P51449 EXPRESSION TAG SEQADV 7JTM ARG A 260 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 261 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 262 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 263 UNP P51449 EXPRESSION TAG SEQADV 7JTM MET A 264 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 509 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 510 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 511 UNP P51449 EXPRESSION TAG SEQADV 7JTM SER A 512 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 513 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLY A 514 UNP P51449 EXPRESSION TAG SEQADV 7JTM LEU A 515 UNP P51449 EXPRESSION TAG SEQADV 7JTM THR A 516 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLU A 517 UNP P51449 EXPRESSION TAG SEQADV 7JTM ARG A 518 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 519 UNP P51449 EXPRESSION TAG SEQADV 7JTM LYS A 520 UNP P51449 EXPRESSION TAG SEQADV 7JTM ILE A 521 UNP P51449 EXPRESSION TAG SEQADV 7JTM LEU A 522 UNP P51449 EXPRESSION TAG SEQADV 7JTM HIS A 523 UNP P51449 EXPRESSION TAG SEQADV 7JTM ARG A 524 UNP P51449 EXPRESSION TAG SEQADV 7JTM LEU A 525 UNP P51449 EXPRESSION TAG SEQADV 7JTM LEU A 526 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLN A 527 UNP P51449 EXPRESSION TAG SEQADV 7JTM GLU A 528 UNP P51449 EXPRESSION TAG SEQRES 1 A 285 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 285 LEU VAL PRO ARG GLY SER HIS MET ALA SER LEU THR GLU SEQRES 3 A 285 ILE GLU HIS LEU VAL GLN SER VAL CYS LYS SER TYR ARG SEQRES 4 A 285 GLU THR CYS GLN LEU ARG LEU GLU ASP LEU LEU ARG GLN SEQRES 5 A 285 ARG SER ASN ILE PHE SER ARG GLU GLU VAL THR GLY TYR SEQRES 6 A 285 GLN ARG LYS SER MET TRP GLU MET TRP GLU ARG CYS ALA SEQRES 7 A 285 HIS HIS LEU THR GLU ALA ILE GLN TYR VAL VAL GLU PHE SEQRES 8 A 285 ALA LYS ARG LEU SER GLY PHE MET GLU LEU CYS GLN ASN SEQRES 9 A 285 ASP GLN ILE VAL LEU LEU LYS ALA GLY ALA MET GLU VAL SEQRES 10 A 285 VAL LEU VAL ARG MET CYS ARG ALA TYR ASN ALA ASP ASN SEQRES 11 A 285 ARG THR VAL PHE PHE GLU GLY LYS TYR GLY GLY MET GLU SEQRES 12 A 285 LEU PHE ARG ALA LEU GLY CYS SER GLU LEU ILE SER SER SEQRES 13 A 285 ILE PHE ASP PHE SER HIS SER LEU SER ALA LEU HIS PHE SEQRES 14 A 285 SER GLU ASP GLU ILE ALA LEU TYR THR ALA LEU VAL LEU SEQRES 15 A 285 ILE ASN ALA HIS ARG PRO GLY LEU GLN GLU LYS ARG LYS SEQRES 16 A 285 VAL GLU GLN LEU GLN TYR ASN LEU GLU LEU ALA PHE HIS SEQRES 17 A 285 HIS HIS LEU CYS LYS THR HIS ARG GLN SER ILE LEU ALA SEQRES 18 A 285 LYS LEU PRO PRO LYS GLY LYS LEU ARG SER LEU CYS SER SEQRES 19 A 285 GLN HIS VAL GLU ARG LEU GLN ILE PHE GLN HIS LEU HIS SEQRES 20 A 285 PRO ILE VAL VAL GLN ALA ALA PHE PRO PRO LEU TYR LYS SEQRES 21 A 285 GLU LEU PHE SER THR SER GLY GLY SER GLY GLY LEU THR SEQRES 22 A 285 GLU ARG HIS LYS ILE LEU HIS ARG LEU LEU GLN GLU HET VK7 A4000 66 HETNAM VK7 TRANS-4-[(3AR,9BR)-8-CYANO-9B-[(4-FLUOROPHENYL) HETNAM 2 VK7 SULFONYL]-7-(1,1,1,2,3,3,3-HEPTAFLUOROPROPAN-2-YL)-1, HETNAM 3 VK7 2,3A,4,5,9B-HEXAHYDRO-3H-BENZO[E]INDOLE-3- HETNAM 4 VK7 CARBONYL]CYCLOHEXANE-1-CARBOXYLIC ACID FORMUL 2 VK7 C30 H26 F8 N2 O5 S FORMUL 3 HOH *43(H2 O) HELIX 1 AA1 SER A 266 THR A 284 1 19 HELIX 2 AA2 ARG A 288 GLN A 295 1 8 HELIX 3 AA3 SER A 301 LYS A 311 1 11 HELIX 4 AA4 SER A 312 LEU A 338 1 27 HELIX 5 AA5 CYS A 345 MET A 365 1 21 HELIX 6 AA6 GLY A 384 GLY A 392 5 9 HELIX 7 AA7 CYS A 393 ALA A 409 1 17 HELIX 8 AA8 SER A 413 ILE A 426 1 14 HELIX 9 AA9 GLU A 435 THR A 457 1 23 HELIX 10 AB1 ARG A 459 LEU A 466 5 8 HELIX 11 AB2 PRO A 468 HIS A 490 1 23 HELIX 12 AB3 HIS A 490 PHE A 498 1 9 HELIX 13 AB4 PRO A 499 SER A 507 1 9 HELIX 14 AB5 ILE A 521 GLU A 528 1 8 SHEET 1 AA1 3 TYR A 369 ASN A 370 0 SHEET 2 AA1 3 THR A 375 PHE A 378 -1 O THR A 375 N ASN A 370 SHEET 3 AA1 3 LYS A 381 GLY A 383 -1 O LYS A 381 N PHE A 378 SITE 1 AC1 20 GLN A 286 LEU A 287 CYS A 320 ALA A 321 SITE 2 AC1 20 HIS A 323 LEU A 324 MET A 358 ARG A 364 SITE 3 AC1 20 MET A 365 ARG A 367 PHE A 378 PHE A 388 SITE 4 AC1 20 LEU A 391 LEU A 396 ILE A 397 ILE A 400 SITE 5 AC1 20 PHE A 401 HIS A 479 HOH A4103 HOH A4106 CRYST1 61.849 61.849 157.720 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016168 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016168 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006340 0.00000